$36.26
+0.22 (+0.60%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+11.93%
1Y
+61.78%
YTD
+7.10%
Open$36.07
Previous Close$36.04
Day High$36.91
Day Low$36.07
52W High$40.58
52W Low$22.09
Volume—
Avg Volume805.9K
Market Cap3.38B
P/E Ratio—
EPS$-1.60
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$34.24
Above
SMA 200
$27.52
Above
RSI (14)
49.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
+224.6% upside
Current
$36.26
$36.26
Target
$117.67
$117.67
$81.99
$117.67 avg
$158.58
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 235.02M | 144.59M | 384.15M |
| Net Income | -122,172,345 | -67,648,031 | -80,984,777 |
| Profit Margin | -52.0% | -49.4% | -21.1% |
| EBITDA | -168,287,675 | -98,359,352 | -85,173,040 |
| Free Cash Flow | — | — | -100,075,430 |
| Rev Growth | +62.5% | +62.5% | -7.8% |
| Debt/Equity | — | — | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |